Dermatophagoides Pteronyssinus (503)

2 trials VVarious

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

1 Countries

Phase II/III

Phase II/III: 2

Sponsors using this IMP

ROXALL Medizin GmbH 2

All trials

2 total

Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy Ended

2023-505880-35-00 Phase II/III 1 country ROXALL Medizin GmbH
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy Ended

2023-505567-37-00 Phase II/III 1 country ROXALL Medizin GmbH

Showing 1–2 of 2 trials

← All drugs A–Z